Zobrazeno 1 - 5
of 5
pro vyhledávání: '"John M. Boulos"'
Autor:
Ross M. Boyce, Alan M. Sanfilippo, John M. Boulos, Meghan Cleinmark, John Schmitz, Steve Meshnick
Publikováno v:
Emerging Infectious Diseases, Vol 24, Iss 11, Pp 2087-2090 (2018)
Nearly two thirds of persons suspected of having tickborne illness in central North Carolina, USA, were not tested for Ehrlichia. Failure to test may have resulted in a missed diagnosis for ≈13% of these persons, who were therefore substantially le
Externí odkaz:
https://doaj.org/article/a543831376544e9085d353d56d44adcb
Autor:
John M Boulos, Valeria Fabre, Kate Dzintars, George Jones, Sara E Cosgrove, Fidelia Bernice, Pranita Tamma
Publikováno v:
Open Forum Infectious Diseases
Background Shorter durations have shown similar clinical outcomes as longer durations for uncomplicated (source-controlled) Gram-negative bloodstream infections (BSI). There is limited data on the outcomes of patients with non-pneumococcal streptococ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2968720621af717dc7e63ae7605b6aca
http://europepmc.org/articles/PMC8645043
http://europepmc.org/articles/PMC8645043
143. Modification of Linezolid Restriction Criteria Reduces ICU Gram-positive Antibiotic Consumption
Autor:
John M Boulos, Catherine H Vu, Megan Logan, Bethany R. Shoulders, Barbara A Santevecchi, Stacy A. Voils, Veena Venugopalan, Kathryn E. DeSear
Publikováno v:
Open Forum Infectious Diseases
Background Antibiotic time out (ATO) policies have been proposed by the Centers for Disease Control and Prevention to limit unnecessary use of antibiotics. Critically ill patients are often treated empirically with MRSA-active agents for a prolonged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6edc2bc3fce67238a565054139a736da
http://europepmc.org/articles/PMC7778099
http://europepmc.org/articles/PMC7778099
Publikováno v:
Chemical Biology & Drug Design. 91:93-104
Muscarinic receptors are known to play important biological roles and are drug targets for several human diseases. In a pilot study, novel muscarinic antagonists were synthesized and used as chemical probes to obtain additional information of the mus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47b579d475c0acbbac04c6b9a5286c50
https://doi.org/10.1111/cbdd.13059
https://doi.org/10.1111/cbdd.13059
Autor:
Meghan Cleinmark, Ross M. Boyce, John M. Boulos, Alan M. Sanfilippo, Steven R. Meshnick, John L. Schmitz
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 24, Iss 11, Pp 2087-2090 (2018)
Emerging Infectious Diseases, Vol 24, Iss 11, Pp 2087-2090 (2018)
Nearly two thirds of persons suspected of having tickborne illness in central North Carolina, USA, were not tested for Ehrlichia. Failure to test may have resulted in a missed diagnosis for ≈13% of these persons, who were therefore substantially le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c08049e7fbc741ec60bd62c24929147
https://pubmed.ncbi.nlm.nih.gov/30334725
https://pubmed.ncbi.nlm.nih.gov/30334725